Metabolic Labeling of Surface Neo-sialylglyconjugates Catalyzed by Trypanosoma cruzi trans-Sialidase.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 25 7 2019
Statut: ppublish

Résumé

Trypanosoma cruzi, the protozoan agent of Chagas disease, has evolved an innovative metabolic pathway by which protective sialic acid (SA) residues are scavenged from host sialylglycoconjugates and transferred onto parasite surface mucin-like molecules (or surface glycoconjugates from host target cells) by means of a unique trans-sialidase (TS) enzyme. TS-induced changes in the glycoprotein sialylation profile of both parasite and host cells are crucial for the establishment of a persistent T. cruzi infection and for the development of Chagas disease-associated pathogenesis. In this chapter, we describe a novel metabolic labeling method developed in our labs that enables straightforward identification and molecular characterization of SA acceptors of the TS-catalyzed reaction.

Identifiants

pubmed: 30868524
doi: 10.1007/978-1-4939-9148-8_10
pmc: PMC6749821
mid: NIHMS1047420
doi:

Substances chimiques

Glycoproteins 0
Protozoan Proteins 0
trans-sialidase EC 3.2.1.-
Neuraminidase EC 3.2.1.18
N-Acetylneuraminic Acid GZP2782OP0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

135-146

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI104531
Pays : United States

Références

J Infect Dis. 1999 Oct;180(4):1398-402
pubmed: 10479182
J Cell Sci. 2000 Apr;113 ( Pt 7):1299-307
pubmed: 10704380
Mol Biochem Parasitol. 2001 May;114(2):143-50
pubmed: 11378194
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3896-901
pubmed: 11891302
J Immunol. 2002 May 15;168(10):5192-8
pubmed: 11994475
J Biol Chem. 2002 Nov 29;277(48):45962-8
pubmed: 12237289
Mol Cell. 2002 Oct;10(4):757-68
pubmed: 12419220
J Am Chem Soc. 2003 Jun 25;125(25):7532-3
pubmed: 12812490
Infect Immun. 2005 Jan;73(1):201-7
pubmed: 15618155
Microbes Infect. 2006 Feb;8(2):401-9
pubmed: 16253534
Nat Rev Microbiol. 2006 Mar;4(3):229-36
pubmed: 16489349
Eur J Immunol. 2006 Jun;36(6):1474-85
pubmed: 16688679
Cell Microbiol. 2006 Jul;8(7):1086-95
pubmed: 16819962
Methods Enzymol. 2006;415:230-50
pubmed: 17116478
Cell. 1991 Jun 28;65(7):1117-25
pubmed: 1712251
Parasitology. 2007 Apr;134(Pt 4):503-10
pubmed: 17166319
Cell Microbiol. 2008 Jan;10(1):88-99
pubmed: 17672865
Biochemistry. 2008 Mar 18;47(11):3507-12
pubmed: 18284211
Nucleic Acids Res. 2009 Jun;37(10):3407-17
pubmed: 19336417
J Biol Chem. 2010 Apr 30;285(18):13388-96
pubmed: 20106975
Glycobiology. 2010 Jul;20(7):833-42
pubmed: 20354005
Carbohydr Res. 2011 Sep 6;346(12):1389-93
pubmed: 21645882
Biochem J. 2011 Sep 1;438(2):303-13
pubmed: 21651499
Biochem J. 2012 Jun 1;444(2):211-8
pubmed: 22428617
J Biol Chem. 2012 Jul 27;287(31):26365-76
pubmed: 22707724
Glycoconj J. 2013 Oct;30(7):659-66
pubmed: 23430107
Microbes Infect. 2013 May;15(5):365-74
pubmed: 23481510
Nat Immunol. 2013 May;14(5):514-22
pubmed: 23563688
Mol Biochem Parasitol. 1985 Jun;16(1):85-96
pubmed: 2412116
Bioorg Med Chem. 2015 Mar 15;23(6):1213-22
pubmed: 25703305
Nat Methods. 2015 Jun;12(6):561-7
pubmed: 25894945
Glycobiology. 2015 Nov;25(11):1142-9
pubmed: 26224786
Trends Genet. 2015 Oct;31(10):539-555
pubmed: 26450337
Front Microbiol. 2016 Mar 23;7:348
pubmed: 27047464
PLoS Pathog. 2016 Apr 08;12(4):e1005559
pubmed: 27058585
Front Microbiol. 2016 May 11;7:698
pubmed: 27242722
J Proteomics. 2017 Jan 16;151:182-192
pubmed: 27318177
Trends Parasitol. 2017 Feb;33(2):102-112
pubmed: 27843019
Front Microbiol. 2017 Jul 11;8:1307
pubmed: 28744279
PLoS Negl Trop Dis. 2017 Aug 11;11(8):e0005856
pubmed: 28800609

Auteurs

Giannina Carlevaro (G)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

Andrés B Lantos (AB)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Laboratorio Dr. Lantos, Buenos Aires, Argentina.

Gaspar E Cánepa (GE)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.

María de Los Milagros Cámara (M)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
Instituto de Tecnología, Universidad Argentina de la Empresa (UADE), Buenos Aires, Argentina.

Martín Somoza (M)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

Carlos A Buscaglia (CA)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

Oscar Campetella (O)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.

Juan Mucci (J)

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina. jmucci@unsam.edu.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina. jmucci@unsam.edu.ar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH